Merck inks deal with Unnatural Products; CG Oncology’s upsized IPO; Locus gets $24M from BARDAnews2024-01-23T15:51:36+00:00January 23rd, 2024|Endpoints News|
What virtual physical therapy startup Hinge Health wants in M&Anews2024-01-23T15:36:52+00:00January 23rd, 2024|Endpoints News|
J&J meets Q4 expectations with $21.4B in salesnews2024-01-23T12:24:40+00:00January 23rd, 2024|Endpoints News|
Gene editing delivery biotech GenEdit partners with Genentech, raises another $24Mnews2024-01-23T12:00:37+00:00January 23rd, 2024|Endpoints News|
Turquoise Health raises $30M to use AI to sort through healthcare pricing datanews2024-01-23T12:00:08+00:00January 23rd, 2024|Endpoints News|
Oncology biotech Accent raises $75M to enter the clinicnews2024-01-23T11:00:33+00:00January 23rd, 2024|Endpoints News|
FDA tells CAR-T makers to add boxed warnings of secondary cancernews2024-01-23T10:55:23+00:00January 23rd, 2024|Endpoints News|
Autolus eyes November for potential US approval of Tecartus rivalnews2024-01-22T20:03:54+00:00January 22nd, 2024|Endpoints News|
For clinician-administered drugs, researchers find no association between price increases and OOP cost increasesnews2024-01-22T19:44:50+00:00January 22nd, 2024|Endpoints News|
